Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 1997

View Archived Issues

Use of desbutylhalofantrine for malaria claimed

ICE and apoptosis inhibitors disclosed by SmithKline Beecham

Antineoplastic cryptophycin compounds

Novel dopamine receptor ligands from Purdue Research Foundation/UNC

Lilly reports compounds for postmenopausal syndrome

Merck & Co. prepares cytokine inhibitors

Ibogamine congeners for addiction

Fluoxetine for the management of premature ejaculation

In vitro antitumor activity of lactoferrin

Mechanism of impaired erection with finasteride elucidated

Transurethral alprostadil/prazosin for erectile dysfunction

Nasacort now available for the treatment of allergic rhinitis

Moxisylyte recommended as first-line therapy for erectile dysfunction

Melanotropic peptide effective in men with erectile dysfunction

Initial clinical results with vinpocetine for urge incontinence

Nitrosylated alpha-adrenoceptor antagonists for erectile dysfunction

New COX-2 inhibitor from Searle

Nasal midazolam safe and effective for anterograde amnesia in children undergoing VCUG

DuPont Merck reports orally active acetylcholine release enhancer

Furosemide vs. placebo for nocturnal polyuria

TGF-beta1 antisense vaccine effective in rat prostate cancer model

GG-745 compared to finasteride in BPH patients

Natural interferon gamma introduced in Japan

Schering-Plough's Nasonex approved in U.K. and France

Norian seeks FDA approval for orthopedic applications of Norian SRS

Faulding launches wound care line in Australia and New Zealand

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...